Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Authors
Keywords
-
Journal
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
Volume 72, Issue 11, Pages 1513-1522
Publisher
Oxford University Press (OUP)
Online
2017-07-17
DOI
10.1093/gerona/glx137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy
- (2017) Joshua M. Hare et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
- (2017) Samuel Golpanian et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Hypoactive Sexual Desire Disorder
- (2017) Irwin Goldstein et al. MAYO CLINIC PROCEEDINGS
- Comparing the predictive accuracy of frailty, comorbidity, and disability for mortality: a 1-year follow-up in patients hospitalized in geriatric wards
- (2017) Martin Ritt et al. Clinical Interventions in Aging
- Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure
- (2016) Rosalinda Madonna et al. EUROPEAN HEART JOURNAL
- Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue
- (2016) Samuel Golpanian et al. PHYSIOLOGICAL REVIEWS
- Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty
- (2016) Samuel Golpanian et al. Oncotarget
- A proteomic analysis of chondrogenic, osteogenic and tenogenic constructs from ageing mesenchymal stem cells
- (2016) Mandy J. Peffers et al. Stem Cell Research & Therapy
- Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease
- (2015) V. Karantalis et al. CIRCULATION RESEARCH
- Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease
- (2015) Samuel Golpanian et al. Stem Cells Translational Medicine
- Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
- (2015) Courtney Premer et al. EBioMedicine
- Stem Cells as Vehicles for Youthful Regeneration of Aged Tissues
- (2014) T. A. Rando et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- The Hallmarks of Aging
- (2013) Carlos López-Otín et al. CELL
- A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD
- (2013) Daniel J. Weiss et al. CHEST
- Frailty in older adults: Implications for end-of-life care
- (2013) K. KOLLER et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Frailty Consensus: A Call to Action
- (2013) John E. Morley et al. Journal of the American Medical Directors Association
- Frailty in elderly people
- (2013) Andrew Clegg et al. LANCET
- Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation
- (2013) Norberto Perico et al. TRANSPLANT INTERNATIONAL
- Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy
- (2012) Joshua M. Hare et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Frailty in Community-Dwelling Older Persons: A Systematic Review
- (2012) Rose M. Collard et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Drug Policy for an Aging Population — The European Medicines Agency's Geriatric Medicines Strategy
- (2012) Francesca Cerreta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation
- (2010) Konstantinos E. Hatzistergos et al. CIRCULATION RESEARCH
- Frailty Defined by Deficit Accumulation and Geriatric Medicine Defined by Frailty
- (2010) Kenneth Rockwood et al. CLINICS IN GERIATRIC MEDICINE
- The Frailty Syndrome: Definition and Natural History
- (2010) Qian-Li Xue CLINICS IN GERIATRIC MEDICINE
- Differential inflammatory responses in aging and disease: TNF-α and IL-6 as possible biomarkers
- (2010) David de Gonzalo-Calvo et al. FREE RADICAL BIOLOGY AND MEDICINE
- Prevalence and 10-Year Outcomes of Frailty in Older Adults in Relation to Deficit Accumulation
- (2010) Xiaowei Song et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Inflammation, Coagulation, and the Pathway to Frailty
- (2009) Bindu Kanapuru et al. AMERICAN JOURNAL OF MEDICINE
- Allogeneic Mesenchymal Precursor Cell Therapy to Limit Remodeling After Myocardial Infarction: The Effect of Cell Dosage
- (2009) Hirotsugu Hamamoto et al. ANNALS OF THORACIC SURGERY
- Immunosenescence: what does it mean to health outcomes in older adults?
- (2009) Janet E McElhaney et al. CURRENT OPINION IN IMMUNOLOGY
- Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy
- (2009) K. H. Schuleri et al. EUROPEAN HEART JOURNAL
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
- (2009) Joshua M. Hare et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intramuscular Transplantation of G-CSF-Mobilized CD34+Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single-Blinded, Dose-Escalation Clinical Trial
- (2009) Atsuhiko Kawamoto et al. STEM CELLS
- Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies
- (2007) A. Stolzing et al. MECHANISMS OF AGEING AND DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now